Vimentin 3, the New Hope, Differentiating RCC versus Oncocytoma

Vimentin is currently used to differentiate between malignant renal carcinomas and benign oncocytomas. Recent reports showing Vimentin positive oncocytomas seriously question the validity of this present diagnostic approach. Vimentin 3 is a spliced variant and ends with a unique C-terminal ending af...

Descripción completa

Detalles Bibliográficos
Autores principales: von Brandenstein, Melanie, Puetz, Katharina, Schlosser, Monika, Löser, Heike, Kallinowski, Joachim P., Gödde, Daniel, Buettner, Reinhard, Störkel, Stefan, Fries, Jochen W. U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405285/
https://www.ncbi.nlm.nih.gov/pubmed/25944973
http://dx.doi.org/10.1155/2015/368534

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405285/
https://www.ncbi.nlm.nih.gov/pubmed/25944973
http://dx.doi.org/10.1155/2015/368534

Ejemplares similares